维普期刊资源整合服务平台（V6.5）

64篇 您的检索式：作者名="Salgaller"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Dendritic cell-based immunotherapy of prostate cancer 显示文摘	TJOA BA LODGE PA	1998	Crit Rev Immunol1998，18，1：	1
2	Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line显示文摘	Robbins PF Kantor JA Salgaller M	1991	Cancer Res1991，51，14：	1
3	Technology evaluation:bevacizumab,Genentech/Roche显示文摘	Salgaller M L	2003	Curr Opin Mol Ther2003，5，6：	1
4	Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line显示文摘	Robbins PF Kantor JA Salgaller M	1991	Cancer Res1991，51，14：	1
5	Dendritic cell - based immunotherapy for prostate cancer 显示文摘	Tjoa BA Lodge PA Salgaller ML	1999	CA Cancer J Clin1999，49，2：	1
6	Cohesive element modeling of viscoelastic fracture: application to peel testing of polymers 显示文摘	Rahulkumar P Bennison S J Salgal S Jagota A	2000	International Journal of Solids and Structures2000，37，13：	1
7	Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity 显示文摘	Zhou Y Bosch ML Salgaller ML	2002	J Immunother2002，25，4：	1
8	Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'- deoxycytidine显示文摘	Weber J Salgaller M Samid D	1994	Cancer Res1994，54，7：	1
9	Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity显示文摘	Zhou Y Bosch ML Salgaller ML	2002	J Immunother2002，25，4：	1
10	Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues 显示文摘	PARKHURST MR SALGALLER ML SOUTHWOOD S	1996	J Immunol1996，157，6：	1
11	Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides显示文摘	SALGALLER ML MARINCOLA FM CORMIER JN	1996	Cancer Res1996，56，20：	1
12	Dendritic cell-based immuntherapy of prostatecancer显示文摘	Salgaller ML Tjoa BA Lodger PA	1998	Crit Rev Immunol1998，18，12：	1
13	Dendritic xellbased immunotherapy of prostate cancer 显示文摘	SALGALLER ML TJOA BA LODGE PA	1998	Crit Rev Immunol1998，18，12：	1
14	Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA) 显示文摘	Salgaller M L Lodge P A McLean J G Tjoa B A Loftus D J Ragde H	1998	Prostate1998，35，：	1
15	Use of cellular and cytokine adju- vants in the immunotherapy of cancer显示文摘	Salgaller ML Lodge PA	1998	J Surg Oncol1998，68，2：	1
16	Dendritic cell-based immunotherapy of prostate cancer显示文摘	Salgaller M L Tjoa B A Lodge P A	1998	Grit Rev Immunol1998，18，1：	1
17	Progress in active-specific immunotherapy of brain malignancies 显示文摘	Tjoa BA Salgaller ML	2000	Expert Opin Investig Drugs2000，9，9：	1
18	Prostate cancer immunotherapy at the dawn of the new millennium显示文摘	Salgaller ML	2000	Expert Opin Investig Drugs2000，9，6：	1
19	Use of cellular and cytokine adjuvants in the immunotherapy of cancer显示文摘	SALGALLER ML LODGE PA	1998	J Surg Oncol1998，68，：	1
20	Current Methods for Loading Dendritic Cells with Tumor Antigen for the Induction of Antitumor Immunity显示文摘	Zhou Y Bosch ML Salgaller ML	2002	J Immunother2002，25，4：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示